SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-19-000269
Filing Date
2019-01-07
Accepted
2019-01-07 06:56:50
Documents
9
Period of Report
2019-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s115220_8k.htm 8-K 66608
2 EXHIBIT 2.1 s115220_ex2-1.htm EX-2.1 799736
3 EXHIBIT 10.1 s115220_ex10-1.htm EX-10.1 89413
4 EXHIBIT 10.2 s115220_ex10-2.htm EX-10.2 100126
5 EXHIBIT 10.3 s115220_ex10-3.htm EX-10.3 44724
6 EXHIBIT 10.4 s115220_ex10-4.htm EX-10.4 55020
7 EXHIBIT 99.1 s115220_ex99-1.htm EX-99.1 35157
8 GRAPHIC img001_v1.jpg GRAPHIC 6541
9 GRAPHIC img002_v1.jpg GRAPHIC 4034
  Complete submission text file 0001615774-19-000269.txt   1206977
Mailing Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE CA 90503 310-214-0065
EMMAUS LIFE SCIENCES, INC. (Filer) CIK: 0001420031 (see all company filings)

IRS No.: 412254389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53072 | Film No.: 19512129
SIC: 6770 Blank Checks